[Transformation of a myelodysplastic to a myeloproliferative syndrome (chronic granulocytic leukemia)]
Related Experiment Videos
Wiener Klinische Wochenschrift
|March 29, 1985
Abstract:
A report is presented of the course of a case of the myelodysplastic syndrome which transformed after 16 months into Philadelphia chromosome-negative chronic granulocytic leukaemia. Such a transformation into the myeloproliferative syndrome is considered to be a rare event and some views on the mechanism of this metamorphosis are discussed.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Chronic myeloid leukemia with a rare variant Philadelphia translocation: t(9;10;22)(q34;q22;q11).
Cancer genetics and cytogenetics·2001
Efficacy and toxicity of 2-Chlorodeoxyadenosine (Cladribine)--2 h infusion for 5 days--as first-line treatment for advanced low grade non-Hodgkin's lymphoma.
European journal of cancer (Oxford, England : 1990)·1999
CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1996
Interferon-alpha for induction and maintenance in multiple myeloma: results of two multicenter randomized trials and summary of other studies.
Annals of oncology : official journal of the European Society for Medical Oncology·1995
Electromagnetic stimulation of the phrenic nerve of intubated patients with obesity : A proof-of-concept study.
Wiener klinische Wochenschrift·2026
Overtriage of a physician-staffed prehospital emergency resource in Austria : An exploratory retrospective analysis.
Wiener klinische Wochenschrift·2026
Dynamic course and outcomes of acute-on-chronic liver failure in the intensive care unit : Insights from a real-world cohort.
Wiener klinische Wochenschrift·2026
Leveraging non-concurrent controls for time-to-event endpoints in platform trials for infectious diseases.
Journal of biopharmaceutical statistics·2026
C5aR1 and C5aR2 deficiency confer different degrees of protection against imiquimod-induced psoriasiform dermatitis.
Clinical and experimental immunology·2026
An Observational Study of Programmed Cell Death In Hypertrophic Scars and Keloids Based on Bibliometric Analysis.
The Journal of craniofacial surgery·2026